Cornerstone Capital Management Holdings’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
$345K Buy
6,471
+100
+2% +$5.33K ﹤0.01% 1062
2017
Q3
$379K Buy
6,371
+300
+5% +$17.8K ﹤0.01% 1094
2017
Q2
$478K Sell
6,071
-105
-2% -$8.27K ﹤0.01% 1045
2017
Q1
$511K Buy
+6,176
New +$511K ﹤0.01% 1057
2015
Q4
Sell
-1,000
Closed -$74K 1556
2015
Q3
$74K Buy
+1,000
New +$74K ﹤0.01% 1369